Source: Fox News
Summary
Scientists have made a breakthrough in developing a vaccine against enterotoxigenic Escherichia coli (ETEC), a bacterium that causes millions of diarrheal illnesses each year. The technology has been licensed to French vaccine manufacturer Valneva for further development. ETEC disproportionately affects children in low- and middle-income countries, and despite years of research, there is currently no broadly effective vaccine. The researchers focused on a toxin produced by ETEC that has long been considered one of the biggest obstacles to vaccine development.
Our Reading
The advice sounds familiar.
Decades of research have led to a promising step in vaccine development, but the technology is still in its early stages. The approach looks promising, but more work is needed to translate the findings into an actual vaccine. The researchers hope that the vaccine could help protect children against severe forms of diarrheal disease caused by ETEC. The licensing agreement allows Valneva to continue advancing the research, but additional laboratory studies, clinical trials, and regulatory review will be required before the vaccine becomes available. We’ve been here before, waiting for a vaccine to materialize.
Author: Evan Null
